4.6
CiteScore
2.2
Impact Factor
- ISSN 1674-8301
- CN 32-1810/R
4.6
2.2
| Citation: |
Xu Han, Wen Li, Changying Chen, Jiahui Liu, Junxiang Sun, Feifan Wang, Chao Wang, Jialing Mu, Xincheng Gu, Fangyuan Liu, Hankun Xie, Song Yang, Chong Shen. Genetic variants and mRNA expression levels of KLF4 and KLF5 with hypertension: A combination of case-control study and cohort study[J]. The Journal of Biomedical Research, 2025, 39(1): 103-113. DOI: 10.7555/JBR.38.20240208
|
Hypertension (HT) is a major risk factor for cardiovascular diseases. Krüppel-like factors (KLFs) are important transcription factors in eukaryotes. Studies have reported that KLF4 and KLF5 are correlated with several cardiovascular diseases, but population-based studies on associations between HT and KLF4 or KLF5 have rarely been reported. Therefore, the current study investigated the associations of genetic variants and mRNA expression levels of KLF4 and KLF5 with HT, as well as the effects of antihypertensive drugs on the expression levels of these genes. The associations of one single-nucleotide polymorphism (SNP) in KLF4 and three SNPs in KLF5 with HT were analyzed using a combination of case-control and cohort studies. The study populations were selected from a community-based cohort in four regions of Jiangsu province. The risks of HT were estimated through logistic and Cox regression analyses. In addition, mRNA expression levels of KLF4 and KLF5 were detected in 246 controls and 385 HT cases selected from the aforementioned cohort. Among the HT cases, 263 were not taking antihypertensive drugs [AHD(−)] and 122 were taking antihypertensive drugs [AHD(+)]. In the case-control study, SNP rs9573096 (C>T) in KLF5 was significantly associated with an increased risk of HT in the additive model (adjusted odds ratio [OR], 1.106; 95% confidence interval [CI], 1.009 to 1.212). In the cohort study of the normotensive population, rs9573096 in KLF5 was also significantly associated with an increased risk of HT in the additive model (adjusted hazards ratio [HR], 1.199; 95% CI, 1.070 to 1.344). KLF4 and KLF5 mRNA expression levels were significantly higher in the AHD(−) group than in the control group (P < 0.05), but lower in the AHD(+) group than in the AHD(−) group (P < 0.05). The current study demonstrated the associations of KLF4 and KLF5 genetic variants with hypertension, as well as the association of the indicative variations in mRNA expression levels of KLF4 and KLF5 with the risk of hypertension and antihypertensive treatment.
This work was supported by the National Natural Science Foundation of China (Grant Nos. 81872686 and 82173611), the National Key Research and Development Program of China (Grant No. 2018YFC2000703), and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).
The authors would like to express their gratitude to the personnel involved in the baseline survey conducted in Yixing, Siyang, and Jurong.
CLC number: R544.1, Document code: A
The authors reported no conflict of interests.
| [1] |
Beaney T, Schutte AE, Stergiou GS, et al. May measurement month 2019: the global blood pressure screening campaign of the international society of hypertension[J]. Hypertension, 2020, 76(2): 333–341. doi: 10.1161/HYPERTENSIONAHA.120.14874
|
| [2] |
Fan Y, Wu L, Zhuang W. Methylenetetrahydrofolate reductase gene rs1801133 and rs1801131 polymorphisms and essential hypertension risk: a comprehensive analysis[J]. Cardiovasc Ther, 2022, 2022: 2144443. https://pubmed.ncbi.nlm.nih.gov/35284002/
|
| [3] |
Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration[J]. Circ Res, 2007, 100(5): 607–621. doi: 10.1161/01.RES.0000258492.96097.47
|
| [4] |
Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension[J]. Br J Pharmacol, 2019, 176(12): 1818–1828. doi: 10.1111/bph.14427
|
| [5] |
Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation[J]. Circulation, 2004, 110(9): 1103–1107. doi: 10.1161/01.CIR.0000140265.21608.8E
|
| [6] |
Krishnan SM, Sobey CG, Latz E, et al. IL-1β and IL-18: inflammatory markers or mediators of hypertension?[J]. Br J Pharmacol, 2014, 171(24): 5589–5602. doi: 10.1111/bph.12876
|
| [7] |
Palmas W, Ma S, Psaty B, et al. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis[J]. Am J Hypertens, 2007, 20(3): 233–241. doi: 10.1016/j.amjhyper.2006.08.006
|
| [8] |
García-Niño WR, Zazueta C. New insights of Krüppel-like transcription factors in adipogenesis and the role of their regulatory neighbors[J]. Life Sci, 2021, 265: 118763. doi: 10.1016/j.lfs.2020.118763
|
| [9] |
Dong J, Zhang Z, Huang H, et al. miR-10a rejuvenates aged human mesenchymal stem cells and improves heart function after myocardial infarction through KLF4[J]. Stem Cell Res Ther, 2018, 9(1): 151. doi: 10.1186/s13287-018-0895-0
|
| [10] |
Niu X, Zhang J, Zhang L, et al. Weighted gene co-expression network analysis identifies critical genes in the development of heart failure after acute myocardial infarction[J]. Front Genet, 2019, 10: 1214. doi: 10.3389/fgene.2019.01214
|
| [11] |
Yuan Z, Murakoshi N, Xu D, et al. Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets[J]. Life Sci, 2022, 306: 120807. doi: 10.1016/j.lfs.2022.120807
|
| [12] |
Sheikh AQ, Misra A, Rosas IO, et al. Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension[J]. Sci Transl Med, 2015, 7(308): 308ra159. https://pubmed.ncbi.nlm.nih.gov/26446956/
|
| [13] |
Shiojima I, Aikawa M, Suzuki JI, et al. Embryonic smooth muscle myosin heavy chain SMemb is expressed in pressure-overloaded cardiac fibroblasts[J]. Jpn Heart J, 1999, 40(6): 803–818. doi: 10.1536/jhj.40.803
|
| [14] |
Nagai R, Suzuki T, Aizawa K, et al. Significance of the transcription factor KLF5 in cardiovascular remodeling[J]. J Thromb Haemost, 2005, 3(8): 1569–1576. doi: 10.1111/j.1538-7836.2005.01366.x
|
| [15] |
Han Y, Fukuda N, Ueno T, et al. Role of complement 3a in the synthetic phenotype and angiotensin II-production in vascular smooth muscle cells from spontaneously hypertensive rats[J]. Am J Hypertens, 2012, 25(3): 284–289. doi: 10.1038/ajh.2011.214
|
| [16] |
Zempo H, Suzuki JI, Ogawa M, et al. Influence of periostin-positive cell-specific Klf5 deletion on aortic thickening in DOCA-salt hypertensive mice[J]. Hypertens Res, 2016, 39(11): 764–768. doi: 10.1038/hr.2016.65
|
| [17] |
Chen J, Zhao X, Wang H, et al. Common variants in TGFBR2 and miR-518 genes are associated with hypertension in the Chinese population[J]. Am J Hypertens, 2014, 27(10): 1268–1276. doi: 10.1093/ajh/hpu047
|
| [18] |
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the
|
| [19] |
Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous[J]. Am J Hum Genet, 2002, 70(2): 425–434. doi: 10.1086/338688
|
| [20] |
Metzger IF, Luizon MR, Lacchini R, et al. Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in black subjects[J]. Nitric Oxide, 2013, 28: 33–38. doi: 10.1016/j.niox.2012.10.002
|
| [21] |
Chistiakov DA, Orekhov AN, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis[J]. Acta Physiol (Oxf), 2015, 214(1): 33–50. doi: 10.1111/apha.12466
|
| [22] |
Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease[J]. Physiol Rev, 2004, 84(3): 767–801. doi: 10.1152/physrev.00041.2003
|
| [23] |
Yu K, Zheng B, Han M, et al. ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements[J]. Cardiovasc Res, 2011, 90(3): 464–474. doi: 10.1093/cvr/cvr017
|
| [24] |
Zhou G, Hamik A, Nayak L, et al. Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice[J]. J Clin Invest, 2012, 122(12): 4727–4731. doi: 10.1172/JCI66056
|
| [25] |
Murgai M, Ju W, Eason M, et al. KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis[J]. Nat Med, 2017, 23(10): 1176–1190. doi: 10.1038/nm.4400
|
| [26] |
Ghaleb AM, Yang VW. Krüppel-like factor 4 (KLF4): what we currently know[J]. Gene, 2017, 611: 27–37. doi: 10.1016/j.gene.2017.02.025
|
| [27] |
Shan F, Huang Z, Xiong R, et al. HIF1α-induced upregulation of KLF4 promotes migration of human vascular smooth muscle cells under hypoxia[J]. J Cell Physiol, 2020, 235(1): 141–150. doi: 10.1002/jcp.28953
|
| [28] |
Yap C, Mieremet A, de Vries CJM, et al. Six shades of vascular smooth muscle cells illuminated by KLF4 (Krüppel-like factor 4)[J]. Arterioscler Thromb Vasc Biol, 2021, 41(11): 2693–2707. doi: 10.1161/ATVBAHA.121.316600
|
| [29] |
Liu Y, Sinha S, Mcdonald OG, et al. Krüppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression[J]. J Biol Chem, 2005, 280(10): 9719–9727. doi: 10.1074/jbc.M412862200
|
| [30] |
Meng G, Xiao Y, Ma Y, et al. Hydrogen sulfide regulates Krüppel-like factor 5 transcription activity via specificity protein 1 S-sulfhydration at Cys664 to prevent myocardial hypertrophy[J]. J Am Heart Assoc, 2016, 5(9): e004160. doi: 10.1161/JAHA.116.004160
|
| [31] |
Wang F, Ge J, Huang S, et al. KLF5/LINC00346/miR-148a-3p axis regulates inflammation and endothelial cell injury in atherosclerosis[J]. Int J Mol Med, 2021, 48(2): 152. doi: 10.3892/ijmm.2021.4985
|
| [32] |
Yang TC, Lu M, Wang W, et al. CEBPB/POU2F2 modulates endothelin 1 expression in prehypertensive SHR vascular smooth muscle cells[J]. J Mol Endocrinol, 2023, 71(1): e220178. https://pubmed.ncbi.nlm.nih.gov/36942826/
|
| [33] |
Yang S, Gao Y, Liu G, et al. The human ATF1 rs11169571 polymorphism increases essential hypertension risk through modifying miRNA binding[J]. FEBS Lett, 2015, 589(16): 2087–2093. doi: 10.1016/j.febslet.2015.06.029
|
| [1] | Liting Lv, Xin Hua, Jiaxin Liu, Sutong Zhan, Qianqian Zhang, Xiao Liang, Jian Feng, Yong Song. Anlotinib reverses osimertinib resistance via inhibiting epithelial-to-mesenchymal transition and angiogenesis in non-small cell lung cancer[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240045 |
| [2] | Sahil Khurana, Ajay Pal Singh, Ashok Kumar, Rajeev Nema. Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma[J]. The Journal of Biomedical Research, 2023, 37(3): 225-228. DOI: 10.7555/JBR.36.20220138 |
| [3] | Wang Jing, He Xuezhi, Lu Xiyi, Amin Karim Muhammad, Miao Dengshun, Zhang Erbao. A novel long non-coding RNA NFIA-AS1 is down-regulated in gastric cancer and inhibits proliferation of gastric cancer cells[J]. The Journal of Biomedical Research, 2019, 33(6): 371-381. DOI: 10.7555/JBR.33.20190015 |
| [4] | Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065 |
| [5] | Yong Ji, Mingfeng Zheng, Shugao Ye, Jingyu Chen, Yijiang Chen. PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer[J]. The Journal of Biomedical Research, 2014, 28(6): 462-467. DOI: 10.7555/JBR.27.20130084 |
| [6] | Keping Xu, Zhi Zhang, Jianqiang Zhao, Jianfeng Huang, Rong Yin, Lin Xu. Partial removal of the pulmonary artery in video-assisted thoracic surgery for non-small cell lung cancer[J]. The Journal of Biomedical Research, 2013, 27(4): 310-317. DOI: 10.7555/JBR.27.20120066 |
| [7] | Songyu Cao, Cheng Wang, Xinen Huang, Juncheng Dai, Lingmin Hu, Yao Liu, Jiaping Chen, Hongxia Ma, Guangfu Jin, Zhibin Hu, Lin Xu, Hongbing Shen. Prognostic assessment of apoptotic gene polymorphisms in non-small cell lung cancer in Chinese[J]. The Journal of Biomedical Research, 2013, 27(3): 231-238. DOI: 10.7555/JBR.27.20130014 |
| [8] | Wenze Sun, Liping Song, Ting Ai, Yingbing Zhang, Ying Gao, Jie Cui. Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer[J]. The Journal of Biomedical Research, 2013, 27(3): 220-230. DOI: 10.7555/JBR.27.20130004 |
| [9] | Li Sun, Xiaoli Fan. Expression of cytochrome P450 2A13 in human non-small cell lung cancer and its clinical significance[J]. The Journal of Biomedical Research, 2013, 27(3): 202-207. DOI: 10.7555/JBR.27.20120019 |
| [10] | Qi Zheng, Yu Yao, Kejun Nan. Weekly intravenous nanoparticle albumin-bound paclitaxel for elderly patients with stage IV non-small-cell lung cancer: a series of 20 cases[J]. The Journal of Biomedical Research, 2012, 26(3): 159-164. DOI: 10.7555/JBR.26.20110106 |
Figures(2) / Tables(3)
Supported by: Beijing Renhe Information Technology Co., Ltd. E-mail:
info@rhhz.net 
Authors and Reviewers
DownLoad: